Breaking News

iBio Receives IBM Clinical Development Solution

Designed to support clinical COVID-19 vaccine candidates.

By: Contract Pharma

Contract Pharma Staff

IBM Watson Health has selected iBio Inc. to receive 18 months of use of the IBM Clinical Development (ICD) solution, free-of-charge.   IBM Watson Health recently began offering its ICD solution to eligible trial sponsor organizations as part of its efforts to help support the medical community to address the COVID-19 pandemic. IBM Watson Health has received interest in the offering from numerous hospitals, sponsors, contract research organizations and academic institutions and is currently enabl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters